AJB ANAESTHETICS LIMITED

🌳Matureactive
08836786 · ltd · incorporated 2014-01-08
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
£242.3k
book net assets
Opportunity
74/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (2 active, 3 linked, 3 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
43 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
74/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £242,281
Cash YoY
+24%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£266k
↑ 24% YoY
Net Worth
£242k
↑ 18% YoY
Current Assets
£386k
↑ 65% YoY
Current Liabilities
£0£77k£154k£231k£309k£386kMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-03-312024-03-31
Total assets£242.3k£204.9k
Current assets£385.8k£234.0k
Cash£266.4k£214.5k
Debtors£119.4k£19.5k
Net assets£242.3k£204.9k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (24 events)Click to expand
  1. 2025-11-10
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2025-04-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  3. 2025-04-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  4. 2025-04-14
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  5. 2025-04-14
    📄
    change-person-director-company-with-change-date
    officers · CH01
  6. 2025-04-14
    📄
    change-person-director-company-with-change-date
    officers · CH01
  7. 2025-01-13
    📄
    change-person-director-company-with-change-date
    officers · CH01
  8. 2025-01-13
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  9. 2025-01-13
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  10. 2025-01-13
    📄
    change-person-director-company-with-change-date
    officers · CH01
  11. 2024-08-23
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  12. 2024-03-04
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  13. 2024-03-04
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  14. 2023-11-07
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2022-09-14
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  16. 2021-09-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  17. 2021-01-13
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  18. 2021-01-13
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  19. 2020-11-01
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  20. 2014-01-09
    BALDOCK, Andrew James appointed
    director
  21. 2014-01-09
    BALDOCK, Rebecca appointed
    director
  22. 2014-01-08
    🏢
    Company incorporated
    As AJB ANAESTHETICS LIMITED
  23. 2014-01-08
    KAHAN, Barbara appointed
    director
  24. 2014-01-08
    KAHAN, Barbara resigned
    director

Owner dependency

66/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.

Succession & seller-readiness

49/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • secondary12+ year tenure: Director in role 12 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mr Andrew James Baldock
Individual · British · DOB 07/1976 · age 50
5075%
50–75%board control50-75% shares · 50-75% voting · board control08/01/2017
Mrs Rebecca Baldock
Individual · British · DOB 06/1979 · age 47
2550%
25–50%board control25-50% shares · 25-50% voting · board control08/01/2017

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · SO postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ABLAZE HEALTHCARE LIMITED
14351404 · est 2022 · no financials extracted
3y
ABSTREAM LIMITED
14039384 · est 2022 · no financials extracted
4y
ACTION24 HEALTHCARE LTD
14900748 · est 2023 · no financials extracted
2y
ADAWHITE CHILAKA CARE SOLUTION LIMITED
17117549 · est 2026 · no financials extracted
AFA SURGICAL LIMITED
12279950 · est 2019 · no financials extracted
6y
AIKA LAUREN LIMITED
14374949 · est 2022 · no financials extracted
3y
AIMA FOSTERING LIMITED
16610195 · est 2025 · no financials extracted
AKENZWORLDWIDE LIMITED LIMITED
13978975 · est 2022 · no financials extracted
4y
AKESISREHAB LTD
15042662 · est 2023 · no financials extracted
2y
AKINSCARE LTD
10861393 · est 2017 · no financials extracted
8y
AKINSCOPER LTD
12593627 · est 2020 · no financials extracted
5y
AKMR HOLDINGS LTD
17003572 · est 2026 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2014-01-08
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities

Registered office

1st Floor, Buckley House 31a
The Hundred
Romsey
Hampshire
SO51 8GD
England

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2027-01-20
Last: 2026-01-06

Officers (2 active · 1 resigned)

BALDOCK, Andrew James
director · ~50y · appointed 2014-01-09
View their other companies + combined net worth →
Active
BALDOCK, Rebecca
director · ~47y · appointed 2014-01-09
View their other companies + combined net worth →
Active
KAHAN, Barbara
director · ~95y · appointed 2014-01-08 · resigned 2014-01-08
Resigned

Click a director name to see their full track record across all companies.

Recent filings (43 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-01-06
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-11-10
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-04-14
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-04-14
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-04-14
change-person-director-company-with-change-date
officers · CH01
2025-04-14
change-person-director-company-with-change-date
officers · CH01
2025-04-14
change-person-director-company-with-change-date
officers · CH01
2025-01-13
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-01-13
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-01-13
change-person-director-company-with-change-date
officers · CH01
2025-01-13
confirmation-statement-with-updates
confirmation-statement · CS01
2025-01-13
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-08-23
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-03-04
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-03-04